Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
12.59
8.97
71.25%
Share Warrants & Outstandings
Total Reserve
-167.80
39.63
-207.43
-523.42%
Shareholder's Funds
-146.24
58.74
-204.98
-348.96%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
25.88
135.37
523.07%
Secured Loans
0.00
25.88
-25.88
-100.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
2.32
-2.32
-100.00%
Other Long Term Liabilities
45.00
0.34
44.66
13,135.29%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
1.29
1.77
137.21%
Total Non-Current Liabilities
211.75
29.84
181.91
609.62%
Current Liabilities
Trade Payables
18.15
10.64
7.51
70.58%
Other Current Liabilities
33.63
3.04
30.59
1,006.25%
Short Term Borrowings
50.96
30.31
20.65
68.13%
Short Term Provisions
0.79
0.90
-0.11
-12.22%
Total Current Liabilities
103.53
44.89
58.64
130.63%
Total Liabilities
169.04
133.47
35.57
26.65%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
86.24
227.87
264.23%
Less: Accumulated Depreciation
168.40
34.50
133.90
388.12%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
51.74
93.96
181.60%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
10.24
-9.00
-87.89%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
9.98
10.33
-0.35
-3.39%
Other Non Current Assets
0.00
3.24
-3.24
-100.00%
Total Non-Current Assets
158.78
76.14
82.64
108.54%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
24.55
-18.52
-75.44%
Sundry Debtors
0.05
21.64
-21.59
-99.77%
Cash and Bank
0.14
4.93
-4.79
-97.16%
Other Current Assets
0.47
0.48
-0.01
-2.08%
Short Term Loans and Advances
3.56
5.72
-2.16
-37.76%
Total Current Assets
10.26
57.33
-47.07
-82.10%
Net Current Assets (Including Current Investments)
-93.27
12.44
-105.71
-849.76%
Total Current Assets Excluding Current Investments
10.26
57.33
-47.07
-82.10%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
133.47
35.57
26.65%
Contingent Liabilities
8.47
7.80
0.67
8.59%
Total Debt
212.21
56.19
156.02
277.67%
Book Value per share (adjusted)
-67.83
41.48
-109.31
-263.52%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






